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ABSTRACT  
In this study the anti-tubercular drug; isoniazid (INH) was investigated for their adverse effect; the oxidative stress. This effect was evaluated 
by using mice model, at the dose of 151 mg/kg.  We found that oxidative stress induced by INH is associated with lipid peroxidation expressed 
by the increase in the level of MDA from 76.9 ± 1.74 to 79.61 ± 2.67 nmol/g tissue. The oxidative stress of INH is accompanied by a decrease in 
reduced GSH level (from 79.9 ± 12 μmol / mg  to 68.48 ± 4.28 μmol / mg compared to of the control group). After treatment wit h INH at 151 
mg/kg, a decrease in CAT activities occurred compared to control (2.53 ± 0.39 U/mg Pr vs 5.07 ± 0.73 U/mg Pr). 
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INTRODUCTION 
Isoniazid (INH), chemically known as isonicotinic acid 
hydrazide, is a low-molecular weight and water-soluble 
compound that can be rapidly absorbed from the 
gastrointestinal tract. INH has been a first-line drug for the 
treatment of tuberculosis for more than 50 years, with 
maximum doses for adult of 300 mg. It inhibits bacterial cell 
wall synthesis, thus killing Mycobacterium tuberculosis 
organisms. Due to its low efficacy towards resistant 
tuberculosis, it is generally used in combination with other 
anti-tubercular drugs such as pyrazinamide, ethambutol, 
and/or rifampicin [1]. In literature, INH is one of oxidative 
drugs. Three principal mechanisms for the oxidative 
reactions of INH; Immune cell products (H2O2 and 
peroxidase) activate INH to pro-oxidant hydrazyl, inducing 
oxidative stress [2]. The damage of lysosomal membrane 
causes ROS formation via Fenton reaction, which induces 
oxidative stress and cytotoxicity. The oxidation of INH leads 
to the formation of nitric oxide radical, causing oxidative 
stress [3,4]. In this study, the oxidative effect of INH was 
evaluated in vivo using mice model, which estimated by lipid 
peroxidation expressed the level of MDA, the activities of 
enzymatic antioxidants such as CAT, and non-enzymatic 
antioxidants such as GSH. 
EXPERIMENTAL SECTION   
In vivo oxidative stress parameters estimation  
In this experiment, INH was used as an oxidizing agent that 
induces oxidative stress in mice. After an 18 h of fasting, INH 
was injected with intraperetenial route at 151 mg/kg [5]. 
The experimental mice were treated as followed: 
Group I: control (untreated), 
Group II: treated with, INH (151 mg/kg) 
After 4 h, animals were scarified.  
Preparation of tissue homogenates 
Liver samples were stored at –4 ºC until homogenation, then 
an amount of 500 mg of liver of the different groups was 
added to 5 mL of the ice KCl buffer (0.15 M). The mixture was 
homogenized at 1200 rpm using electric homogenizer.  
Determination of CAT activity 
The CAT activity was determined in supernatant, obtained 
after a 15 min centrifugation of liver homogenates at 4000–
5000 rpm. The CAT activities were measured as follows: 30 
mM hydrogen peroxide was used as a substrate. To each 
sample, 1.9 mL phosphate buffer (pH 7.2) and 1 mL 30 mM 
H2O2 were added. The decrease in H2O2 concentration at 25 
ºC was spectrophotometrically determined at 240 nm. The 
extinction coefficient was read exactly 1 min after H2O2 
addition. CAT activities presented as units permg protein 
(Units/mg Protein). 
Estimation of GSH 
The GSH levels were estimated in the homogenates of liver 
using (5,5’-dithiobis-(2-nitrobenzoic acid), (DTNB), in which 
5 mL of sodium phosphate buffer (0.1 M, pH = 8) was added 
to 25 μL of supernatant homogenate, then 1.5 mL of the 
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mixture was added to 10 μL of DTNB (0.01 M). 
Determination of GSH is based on the reaction of DTNB with 
GSH to yield a yellow colored chromophore with a maximum 
absorbance at 412 nm. The amount of GSH present in the 
tissue was calculated using its extinction coefficient 
(1.36×104 M−1 cm−1) at 412 nm and expressed as μmoles/g 
tissue [5]. 
Estimation of MDA 
The hepatic malondialdehyde (MDA) content was an 
indicator to determine hepatic lipid peroxidation levels. In 
this experiment, 125 μL of trichloric acid (TCA, 20%) and 
250 μL of thiobarbituric acid (TBA, 0.67%) were added to 
125 μL of tissue homogenate. The mixture was incubated at 
100 °C during 20 min. After incubation, the sample was 
cooled. The MDA-TBA complex was extracted with 1 mL of 
butanol. The organic phase was separated by centrifugation 
at 3000 rpm for 15 min. Absorbance was measured at 530 
nm. The concentration of MDA was calculated using its 
extinction coefficient (1.56×105 M−1 cm−1) at 530 nm and 
expressed as nanomoles MDA/g tissue [6]. 
RESULTS AND DISCUSSION 
Due to the good predicted results and the high free radical-
scavenging effect and to the similar structure to indole-
derivatives, which are considered potential antioxidant 
agents [7], the oxidative stress induced by the drug INH. 
Results of this study indicated that intraperitoneal injections 
of isoniazid at 151 mg/kg led to an increase in 
malondialdehyde (MDA) formation, decrease in the activities 
of enzymatic antioxidants such as CAT, and a decrease in 
non-enzymatic antioxidants such as GSH when compared 
with the control. 
We found that oxidative stress induced by INH is associated 
with lipid peroxidation expressed by the increase in the level 
of MDA from 76.9 ± 1.74 to 79.61 ± 2.67 nmol/g tissue. This 
number was decreased to 68.02 ± 2.27 and 60.46 ± 4.63 
nmol/g tissue. The reduced GSH is one of non-enzymatic 
antioxidant present in the liver which scavenges reactive 
toxic metabolites of anti-tubercular drugs; liver damage was 
observed when GSH stocks were significantly decreased [8]. 
The oxidative stress of INH is accompanied by a decrease in 
reduced GSH level (from 79.9 ± 12 μmol / mg  to 68.48 ± 4.28 
μmol / mg compared to of the control group). Results of the 
enzymatic antioxidant, CAT activities of treated mice are 
presented in Table 1. After treatment with INH at 151 
mg/kg, a decrease in CAT activities occurred compared to 
control (2.53 ± 0.39 U/mg Pr vs 5.07 ± 0.73 U/mg Pr). The 
decreased CAT activity could be due to the enhanced 
generation of ROS during isoniazid metabolism [9] that is 
deactivated by CAT as well as to the activation of the 
peroxide oxidation of lipids, proteins, nucleic acids, and 
other macromolecules. 
  
Table 1. Effect of INH on oxidative stress parameters. 
Groups  CAT (U/mg protein) MDA (nmol/g tissue) GSH (µmol/mg protein) 
Control 5.07 ± 0.19 76.9 ± 1.74 79.90 ± 12 
INH 151 (mg/kg) 2.53 ± 0.63*** 79.61 ± 2.67ns 68.48 ± 4.28*** 
Values expressed as mean ± SEM, n= 5 animals /group;***: p < 0.001, **: p < 0.01,    ns: no significant differences. 
 
CONCLUSION 
Isoniazid increased the consumption of endogenous 
antioxidants which could be responsible for the increasing in 
oxidative stress during their metabolism. 
ABBREVIATIONS  
INH: isoniazid 
ns: no significant differences 
MDA: Malondialdehyde  
GSH: Gluthation  
CAT: Catalase  
Pr: Protein 
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